Brief report: a phase II "window-of-opportunity" frontline study of the MTOR inhibitor, temsirolimus given as a single agent in patients with advanced NSCLC, an NCCTG study.
| Image |  |
|---|---|
| Description | scientific article published in May 2012 |
| Author/s |
author: Kendrith M Rowland Thanyanan Reungwetwattana Steven E Schild Mark Randolph James R Jett Julian R Molina Alex A Adjei Grace K Dy Katie L Allen Ziegler |
| Publication date | May 1, 2012 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |